Munson Health
Related Information
Parkinson's Disease

Back to Document

by Carson-DeWitt R

(PD; Paralysis Agitans; Shaking Palsy)



Symptoms of PD begin mildly. They will worsen over time.
PD may cause:


Currently, there are no treatments to cure PD. There are also no proven treatments to slow or stop its progression. Some medications may help to improve symptoms. Over time, the side effects of the medication may become troublesome. The medications may also lose their effectiveness.


Different brain operations are available, and many more are being researched including:
  • Deep brain stimulation (DBS)—implanting a device to stimulate certain parts of the brain; can decrease tremor and rigidity
  • Thalamotomy and pallidotomy—destroying certain areas of the brain to improve tremor when medication does not work (not as common as deep brain stimulation)
  • Nerve-cell transplants (research only)—to increase amount of dopamine made in the brain

Physical Therapy

Therapy can improve muscle tone, strength, and balance. It includes exercises and stretches. There is also evidence that tai chi may be beneficial.

Psychological Support

Consider joining a support group with other people with PD. It will help to learn how others are learning to live with the challenges of PD.


National Parkinson Foundation

Parkinson's Disease Foundation



Health Canada

Parkinson Society Canada



Alvarez MVG, Evidente VGH. Understanding drug induced parkinsonism: separating pearls from oysters. Neurology. 2008;70:e32-34.

Li F, et al. Tai chi and postural instability in patients with Parkinson’s Disease. N Engl J Med. 2012;366(6):511-5199.

Liu R, Gao X, et al. Meta-analysis of the relationship between Parkinson disease and melanoma. Neurology. 2011;76:2002-2009.

Managing your PD. Parkinson’s Disease Foundation website. Available at: Accessed September 5, 2013.

Nielsen NM, Rostgaard K, et al. Poliomyelitis and Parkinson disease. JAMA. 2002;287:1650-1651.

NINDS Parkinson's disease information page. National Institute of Neurological Disorders and Stroke website. Available at: Updated August 21, 2014. Accessed August 25, 2014.

Obeso JA, et al. Missing pieces in the Parkinson’s disease puzzle. Nature Medicine. 2010;16(6):653-661.

Parkinson disease. EBSCO DynaMed website. Available at: Updated May 27, 2014. Accessed August 25, 2014.

Parkinson's disease. American Association of Neurological Surgeons website. Available at: Accessed August 25, 2014.

Perlmutter JS, Eidelberg D. To scan or not to scan: DaT is the question. Neurology. 2012;78:688-689.

Ristić AJ, Vojvodić N, et al. The frequency of reversible parkinsonism and cognitive decline associated with valproate treatment: a study of 364 patients with different types of epilepsy. Epilepsia. 2006:47(12):2183-2185.

Samii A, et al. Parkinson's disease. Lancet. 2004;363:1783-1793.

Schenkman N, et al. Exercise for people in early- or mid-stage Parkinson disease: a 16-month randomized controlled trial. Phys Ther. 2012.

Siderowf A, et al. Update on Parkinson's disease. Ann Intern Med. 2003;138:651-658.

Wider C, Wszolek CK. Movement disorders: insights into mechanisms and hopes for treatments. Lancet Neurology. 2009;8(1):8-10.

1/4/2011 DynaMed Systematic Literature Surveillance Spinks A, Wasiak J, Bernath V, Villaneuva E. Scopolamine (hyoscine) for preventing and treating motion sickness. Cochrane Database Syst Rev. 2009;(4):CD002851.

4/7/2014 DynaMed Systematic Literature Surveillance Marras C, Hincapié CA, et al. Systematic review of the risk of Parkinson's disease after mild traumatic brain injury: results of the international collaboration on mild traumatic brain injury prognosis. Arch Phys Med Rehabil. 2014 Mar;95(3S):S238-244.

9/3/2014 DynaMed's Systematic Literature Surveillance. Available at: Wippold FJ, Cornelius RS, et al. American College of Radiology (ACR) Appropriateness Criteria for dementia and movement disorders. Available at: Updated 2014. Accessed September 3, 2014.


Revision Information